76 results
Page 2 of 4
6-K
EX-99.1
92ie abri9o4a
6 Jul 22
Current report (foreign)
8:41am
6-K
EX-99.2
cxi558h cv7v
27 May 22
Condensed Consolidated Financial Statements
4:39pm
6-K
EX-99.1
jhdz2j6lid
27 May 22
Condensed Consolidated Financial Statements
4:39pm
6-K
EX-99.1
z228r cucso4z
25 May 22
Enlivex Awarded Its Third Non-Dilutive Israel Innovation Authority Grant
8:05am
6-K
5x3q5dzh fu3nf
25 May 22
Enlivex Awarded Its Third Non-Dilutive Israel Innovation Authority Grant
8:05am
6-K
EX-99.2
fkkhprzv3
19 Nov 21
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
q7w6plygoxaz27quts
19 Nov 21
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
p95twrbbk
30 Sep 21
Annual and Extraordinary General Meeting of Shareholders
8:01am
6-K
EX-99.1
d0imw f28ogk60e
9 Aug 21
Enlivex Announces Second Quarter 2021 Financial Results and Provides a Business Update
8:00am
6-K
EX-99.2
iwo ak5n9ctv3e
6 Aug 21
Condensed Consolidated Financial Statements
4:31pm
6-K
EX-99.1
6myvi4fmra6hosd5xy3m
6 Aug 21
Condensed Consolidated Financial Statements
4:31pm
6-K
EX-99.1
ss4mr7
28 May 21
Condensed Consolidated Financial Statements
4:33pm
6-K
EX-99.2
nc87rbtnaz
28 May 21
Condensed Consolidated Financial Statements
4:33pm
6-K
gd1rbgptciwrb
18 May 21
Enlivex Awarded Second Israel Innovation Authority Grant to Support the Clinical Development of Allocetra in Sepsis
8:03am
6-K
EX-99.1
y2dljuyb0e
18 May 21
Enlivex Awarded Second Israel Innovation Authority Grant to Support the Clinical Development of Allocetra in Sepsis
8:03am
6-K
EX-1.1
8tle3r
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
424B5
k5t3hgo2evs
10 Feb 21
Prospectus supplement for primary offering
5:22pm
424B5
x0ey0nk2nj25opuouj
9 Feb 21
Prospectus supplement for primary offering
4:56pm